Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Budde, Holger ^a   Kolb, Susanne ^a   Tejedor, Laura Salinas ^a   Wulf, Gerald ^a   Reichardt, Holger M ^a   Riggert, Joachim ^a   Legler, Tobias J ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APHERESIS; ARTICLE; BONE MARROW; DISEASE SEVERITY; DONOR; EXTRACORPOREAL PHOTOPHERESIS; IMMUNOLOGICAL TOLERANCE; LEUKOCYTE; MALE; MOUSE; MOUSE MODEL; NONHUMAN; STEM CELL TRANSPLANTATION; ADVERSE EFFECTS; ALLOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; DISEASE MODEL; GRAFT VS HOST DISEASE; IMMUNOLOGY; MORTALITY; PATHOLOGY; PROCEDURES; PUVA; REGULATORY T LYMPHOCYTE;

ALLOGRAFTS; ANIMALS; BLOOD DONORS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; IMMUNE TOLERANCE; MALE; MICE, INBRED BALB C; PHOTOPHERESIS; T-LYMPHOCYTES, REGULATORY;

EID: 84935120764     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105896     Document Type: Article

References (32)

1. Li HW, Sykes M (2012) Emerging concepts in haematopoietic cell transplantation. Nat Rev Immunol 12: 403-16.
2. Shlomchik WD (2007) Graft-versus-host disease. Nat Rev Immunol 7: 340-52.
3. Korngold R, Sprent J (1978) Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 148: 1687-98. (Pubitemid 9084041)
4. Pasquini MC, Wang Z, Horowitz MM, Gale RP (2010) 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl: 87-105.
5. Wolff D, Steiner B, Hildebrandt G, Edinger M, Holler E (2009) Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease. Curr Pharm Des 15: 1974-97.
6. Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, et al. (2008) Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 42: 609-17.
7. Wolf D, von Lilienfeld-Toal M, Wolf AM, Schleuning M, von Bergwelt-Baildon M, et al. (2012) Novel treatment concepts for graft-versus-host disease. Blood 119: 16-25.
8. Blazar BR, Murphy WJ, Abedi M (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12: 443-58.
9. Greinix HT, Worel N, Knobler R (2010) Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 16: 1747-8.
10. Marshall SR (2006) Technology insight: ECP for the treatment of GvHD - can we offer selective immune control without generalized immunosuppression? Nat Clin Pract Oncol 3: 302-14.
11. Hart JW, Shiue LH, Shpall EJ, Alousi AM (2013) Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol 4: 320-34.
12. Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, et al. (2000) Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 96: 2426-31.
13. Suchin KR, Cassin M, Washko R, Nahass G, Berkson M, et al. (1999) Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 41: 980-6.
14. Merlin E, Paillard C, Rochette E, David A, Isfan F, et al. (2010) Extracorporeal photochemotherapy as second- or first-line therapy of acute GVHD? Bone Marrow Transplant 45: 963-5.
15. Heshmati F (2003) Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 29: 61-70.
16. Albert ML (2004) Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 4: 223-31.
17. Xia CQ, Campbell KA, Clare-Salzler MJ (2009) Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Curr Opin Organ Transplant 14: 338-43.
18. Tischner D, Theiss J, Karabinskaya A, van den Brandt J, Reichardt SD, et al. (2011) Acid sphingomyelinase is required for protection of effector memory T cells against glucocorticoid-induced cell death. J Immunol 187: 4509-16.
19. Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, et al. (2012) Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 109: 564-9.
20. Schroeder MA, DiPersio JF (2011) Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech 4: 318-33.
21. Reddy P and Ferrara JLM (2009) Mouse models of graft-versus-host disease. StemBook, ed. The Stem Cell Research Community. doi/10.3824/stembook.1.36.1.
22. Wolf CE, Meyer M, Riggert J. (2005) Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: product quality and prediction of the yield using different harvest procedures. Vox Sang 88: 249-55. (Pubitemid 40704898)
23. Reddy P, Negrin R, Hill GR (2008) Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant 14: 129-35. (Pubitemid 350286851)
24. Devine SM, Carter S, Soiffer RJ, Pasquini MC, Hari PN, et al. (2011) Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303. Biol Blood Marrow Transplant 17: 1343-51.
25. Gatza E, Rogers CE, Clouthier SG, Lowler KP, Tawara I, et al. (2008) Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 112: 1515-21.
26. Maeda A, Schwarz A, Bullinger A, Morita A, Peritt D, et al. (2008). Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol. 181: 5956-62.
27. Greinix HT, Socié G, Bacigalupo A, Holler E, Edinger MG, et al. (2006) Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 38: 265-73. (Pubitemid 44203776)
28. Birge RB, Ucker DS (2008) Innate apoptotic immunity: the calming touch of death. Cell Death Differ 15: 1096-102. (Pubitemid 351850961)
29. Capitini CM, Davis JP, Larabee SM, Herby S, Nasholm NM, et al. (2011) Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination. Biol Blood Marrow Transplant 17: 790-9.
30. Edelson RL (2013) Mechanistic insights into extracorporeal photochemotherapy: Efficient induction of monocyte-to-dendritic cell maturation. Transfus Apher Sci: doi:10.1016/j.transci.2013.07.031.
31. Gasparro FP, Dall'Amico R, Goldminz D, Simmons E, Weingold D (1989) Molecular aspects of extracorporeal photochemotherapy. Yale J Biol Med 62: 579-93. (Pubitemid 20201939)
32. Bladon J, Taylor PC (2006) Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 43: 85-94. (Pubitemid 44094006)